Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RGEN | REPLIGEN CORP | Director | $12.8M | May 15, 2025 | ||
BRNS | Barinthus Biotherapeutics plc. | Director | Jun 10, 2025 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|